BiotechTube
Home/Annexon Biosciences/Douglas Love, Esq.
DL

Douglas Love, Esq.

President & Chief Executive Officer

Annexon Biosciences

Roles

President & Chief Executive OfficeratAnnexon Biosciences
President & Chief Executive OfficeratAnnexon

Therapeutic Areas

AutoimmuneNeurodegenerativeOphthalmic

Annexon Biosciences Pipeline

DrugIndicationPhase
ANX005Guillain-Barré Syndrome (GBS)Phase 3
ANX007Geographic Atrophy (GA)Phase 2
ANX009Undisclosed (Blood/Targeted)Phase 1
ANX1502Undisclosed (Oral)Phase 1

Leadership Team at Annexon Biosciences

TY
Ted Yednock, PhD
EVP & Chief Innovation Officer
JD
Jamie Dananberg, M.D.
EVP & Chief Medical Officer
RA
Rick Artis, PhD
Chief Scientific Officer
JL
Jennifer Lew
EVP & Chief Financial Officer
MO
Michael Overdorf, MBA
EVP & Chief Business Officer
TG
Thomas G. Wiggans
Board Chair
DB
Dr. Ben Barres
Scientific Co-Founder (deceased)
View full Annexon Biosciences profile